Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

PHASE3CompletedINTERVENTIONAL
Enrollment

5,803

Participants

Timeline

Start Date

September 1, 2005

Primary Completion Date

October 12, 2006

Study Completion Date

October 12, 2006

Conditions
VaricellaChickenpox Vaccines
Interventions
BIOLOGICAL

Priorix-tetra™

2 doses administered subcutaneously, one at Day 0 and the other at Day 42 to subjects in MMRV Group

BIOLOGICAL

Priorix™

2 doses administered subcutaneously, one at Day 0 and the other at Day 42 to subjects in MMR Group and one dose administered subcutaneously at Day 0 to subjects in OKAH Group

BIOLOGICAL

Varilrix™

1 dose administered subcutaneously at Day 42 to subjects in OKAH Group

Trial Locations (104)

1319

GSK Investigational Site, Bekkestua

5231

GSK Investigational Site, Paradis

14200

GSK Investigational Site, Prague

16132

GSK Investigational Site, Genoa

20122

GSK Investigational Site, Milan

20395

GSK Investigational Site, Bucharest

22100

GSK Investigational Site, Tripoli

22102

GSK Investigational Site, Bucharest

25236

GSK Investigational Site, Athens

28002

GSK Investigational Site, Kolín

28100

GSK Investigational Site, Novara

33100

GSK Investigational Site, Udine

43003

GSK Investigational Site, Chomutov

43100

GSK Investigational Site, Karditsa

44100

GSK Investigational Site, Ferrara

46015

GSK Investigational Site, Liberec

50139

GSK Investigational Site, Florence

50200

GSK Investigational Site, Ptolemaida

54636

GSK Investigational Site, Thessaloniki

80010

GSK Investigational Site, Quarto (NA)

115446

GSK Investigational Site, Moscow

119991

GSK Investigational Site, Moscow

141280

GSK Investigational Site, Ivanteevka Moscow Region

183046

GSK Investigational Site, Murmansk

191123

GSK Investigational Site, Saint Petersburg

300593

GSK Investigational Site, Timișoara

400130

GSK Investigational Site, Volgograd

400217

GSK Investigational Site, Cluj-Napoca

410010

GSK Investigational Site, Saratov

443079

GSK Investigational Site, Samara

620085

GSK Investigational Site, Yekaterinburg

620109

GSK Investigational Site, Yekaterinburg

630112

GSK Investigational Site, Novosibirsk

634001

GSK Investigational Site, Tomsk

654063

GSK Investigational Site, Novokuznetsk

900709

GSK Investigational Site, Constanța

628 00

GSK Investigational Site, Brno

405 01

GSK Investigational Site, Děčín

580 22

GSK Investigational Site, Havlíčkův Brod

500 01

GSK Investigational Site, Hradec Králové

396 01

GSK Investigational Site, Humpolec

377 01

GSK Investigational Site, Jindřichův Hradec

702 00

GSK Investigational Site, Moravská Ostrava

547 01

GSK Investigational Site, Náchod

728 92

GSK Investigational Site, Ostrava

532 03

GSK Investigational Site, Pardubice

305 99

GSK Investigational Site, Pilsen

140 00

GSK Investigational Site, Prague

150 00

GSK Investigational Site, Prague

160 00

GSK Investigational Site, Prague

190 00

GSK Investigational Site, Prague

Unknown

GSK Investigational Site, Znojmo

GSK Investigational Site, Brasov

GSK Investigational Site, Sibiu

471 00

GSK Investigational Site, Arta

115 22

GSK Investigational Site, Athens

115 27

GSK Investigational Site, Athens

581 00

GSK Investigational Site, Giannitsá

69 100

GSK Investigational Site, Komotini

591 00

GSK Investigational Site, Véria

07041

GSK Investigational Site, Alghero (SS)

07014

GSK Investigational Site, Ozieri (SS)

LT-63164

GSK Investigational Site, Alytus

LT-48259

GSK Investigational Site, Kaunas

LT-94007

GSK Investigational Site, Klaipėda

LT-37355

GSK Investigational Site, Panevezys

LT-76346

GSK Investigational Site, Šiauliai

LT -10207

GSK Investigational Site, Vilnius

LT-02169

GSK Investigational Site, Vilnius

LT-11200

GSK Investigational Site, Vilnius

N-2390

GSK Investigational Site, Moelv

N-03730

GSK Investigational Site, Skien

N-7036

GSK Investigational Site, Trondheim

85-021

GSK Investigational Site, Bydgoszcz

39-200

GSK Investigational Site, Dębica

31-202

GSK Investigational Site, Krakow

56-400

GSK Investigational Site, Oleśnica

61-709

GSK Investigational Site, Poznan

41-103

GSK Investigational Site, Siemianowice Śląskie

33-100

GSK Investigational Site, Tarnów

55-100

GSK Investigational Site, Trzebnica

05-077

GSK Investigational Site, Wesoła

52-312

GSK Investigational Site, Wroclaw

050098

GSK Investigational Site, Bucharest

077190

GSK Investigational Site, Bucharest

115 478

GSK Investigational Site, Moscow

841 08

GSK Investigational Site, Bratislava

851 05

GSK Investigational Site, Bratislava

027 55

GSK Investigational Site, Dlhá nad Oravou

026 01

GSK Investigational Site, Dolný Kubín

018 41

GSK Investigational Site, Dubnica nad Váhom

018 51

GSK Investigational Site, Nová Dubnica

915 01

GSK Investigational Site, Nové Mesto nad Váhom

940 01

GSK Investigational Site, Nové Zámky

020 01

GSK Investigational Site, Púchov

034 01

GSK Investigational Site, Ružomberok

943 01

GSK Investigational Site, Štúrovo

942 18

GSK Investigational Site, Šurany

911 01

GSK Investigational Site, Trenčín

SE-581 85

GSK Investigational Site, Linköping

205 02

GSK Investigational Site, Malmo

SE-602 39

GSK Investigational Site, Norrköping

SE-702 11

GSK Investigational Site, Örebro

SE-901 85

GSK Investigational Site, Umeå

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00226499 - Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox | Biotech Hunter | Biotech Hunter